Related Experiment Video
Updated: Oct 6, 2025
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Decrease in MAP3Ks expression enhances the cell death caused by hyperthermia
Atsushi Enomoto1, Takemichi Fukasawa1,2, Hiroshi Terunuma3
1Laboratory of Molecular Radiology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Purpose:
Hyperthermia is a promising anticancer treatment modality. However, the molecular mechanism underlying the thermal sensitivity of tumor cells is largely unknown. The aim of this study was to clarify how biochemical changes triggered by heat stimulate antitumor activity.
Methods And Materials:
The expression levels of various MAPK members in HeLa cells with or without hyperthermia were evaluated by western blotting and RT-PCR. The intracellular Ca2+ concentration [Ca2+]i was monitored by digital imaging using CaTM-2 AM. An in vitro cleavage assay was used to determine whether calcium-dependent protease calpain cleaves MAPK components. Cell proliferation and clonogenicity were assessed in the absence or presence of siRNAs targeting MAPK members.
Results:
Hyperthermia decreased the levels of MAP3K TAK1, RAF1 and MEKK2 but not of the downstream MAP2K and MAPK members. The hyperthermia-induced degradation of TAK1 and MEKK2 was rescued by either the proteasome inhibitor MG132 or the calpain inhibitor ALLN; however, RAF1 was not affected by the inhibitors. Heat induced down regulation of RAF1. Hyperthermia increased [Ca2+]i and calpain I expression. The calcium ionophore A23187 decreased TAK1 and MEKK2 levels. An in vitro cleavage assay demonstrated that TAK1 and MEKK2 are calpain I substrates. Knockdown of TAK1, RAF1 and MEKK2 suppressed cell proliferation and clonogenicity.
Conclusions:
Hyperthermia decreased the levels of MAP3K TAK1, RAF1 and MEKK2, without reduction of the downstream components in the MAP3K-MAP2K-MAPK cascade, by a calpain-dependent degradation pathway or transcriptional regulation. TAK1, RAF1 and/or MEKK2 play crucial roles in cell proliferation and clonogenicity and are potential molecular targets for hyperthermia.
Insights
Hyperthermia triggers cancer cell death by reducing key proteins TAK1, RAF1, and MEKK2. These MAP3K proteins are crucial for cell proliferation and clonogenicity, making them potential targets for anticancer therapies.
Area of Science:
- Biochemistry
- Molecular Oncology
- Cell Biology
Background:
- Hyperthermia is a recognized anticancer treatment.
- The precise molecular mechanisms behind thermal sensitivity in tumor cells remain unclear.
- Understanding these mechanisms is vital for optimizing hyperthermia as a therapeutic strategy.
Purpose of the Study:
- To elucidate the biochemical alterations induced by heat that contribute to antitumor activity.
- To investigate the role of Mitogen-Activated Protein Kinase (MAPK) pathway components in hyperthermia-induced cell death.
- To identify specific molecular targets within the MAPK pathway affected by hyperthermia.
Main Methods:
- Western blotting and RT-PCR were used to assess MAPK member expression in HeLa cells.
- Intracellular calcium levels ([Ca2+]i) were monitored using digital imaging.
- Calpain activity and its role in MAPK component cleavage were examined via in vitro assays.
- Cell proliferation and clonogenicity were evaluated using siRNA knockdown of specific MAPK members.
Main Results:
- Hyperthermia decreased levels of MAP3K members TAK1, RAF1, and MEKK2, but not downstream MAP2K or MAPK components.
- Heat-induced degradation of TAK1 and MEKK2 was mediated by calpain and proteasome pathways.
- RAF1 downregulation was observed, independent of proteasome or calpain inhibition.
- Increased intracellular calcium and calpain I expression correlated with hyperthermia.
- Knockdown of TAK1, RAF1, or MEKK2 significantly suppressed cell proliferation and clonogenicity.
Conclusions:
- Hyperthermia reduces specific MAP3K proteins (TAK1, RAF1, MEKK2) via calpain-dependent degradation or transcriptional changes.
- These MAP3K proteins are critical for tumor cell proliferation and clonogenicity.
- TAK1, RAF1, and MEKK2 represent potential molecular targets for enhancing hyperthermia-based cancer treatments.
Related Concept Videos
01:07MAPK Signaling Cascades
02:23Abnormal Proliferation
01:31The Intrinsic Apoptotic Pathway
01:17The Extrinsic Apoptotic Pathway